欢迎参加第七届中青年呼吸医师论坛
2010中国普外科焦点问题学术论坛欢迎您
Chinese Medical Journal
Home | Current issue | Past issues | News Press | Information | Contact us | Submission
Own by Chinese Medical Association
 
IF in 2008: 0.858
  Function Box
·LogIn/LogOut
·Fulltext Fulltext HTMLHTML Free
·Fulltext Full PDFPDF(-) Free
·Abstract download
TXT | XML
· Articles in CMJ by
XIAO Dan
WANG Chen
·Articles in PubMed by
XIAO D
WANG C
·Put into my bookshelf
·Email Alert
·Email to Friend
·Email to author
·Visit:5953
·Download:3214
·Related Articles
·Advanced Search
·Cannot read some characters
Chinese Medical Journal, 2004, Vol. 117 No. 5:661-667
Relationship between polymorphisms of genes encoding microsomal epoxide hydrolase and glutathione S-transferase P1 and chronic obstructive pulmonary disease
XIAO Dan 肖 丹, WANG Chen 王 辰, DU Min-jie 杜敏捷, PANG Bao-sen 庞宝森, ZHANG Hong-yu 张洪玉, XIAO Bai 肖 白, LIU Jing-zhong 刘敬忠, WENG Xin-zhi 翁心植, SU Li 苏 丽, David C.Christiani
Free Full Text [ Fulltext HTMLHTML | Full PDFPDF(-) ] Abstract download [TXT | XML]
Keywords: pulmonary disease, chronic obstructive·microsomes·epoxide hydrolases·glutathione S-transferase P·polymorphism, genetics
Abstract:

Background Cigarette smoking is the major risk factor for chronic obstructive pulmonary disease (COPD). However, only 10%-20% of chronic heavy cigarette smokers develop symptomatic disease. COPD is most likely the result of complex interactions between environmental and genetic factors. Genetic susceptibility to COPD might depend on the variations in enzyme activities that detoxify cigarette smoke products, such as microsomal epoxide hydrolase (mEH) and glutathione S-transferase (GST). In this study, we investigated the relationship between polymorphisms in the genes encoding mEH and glutathione S-transferase P1 (GSTP1) and COPD in a Chinese population.
Methods Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was performed to find mEH polymorphism in exon 3 (Tyr113→His), exon 4 (His139→Arg) and GSTP1 polymorphism in exon 5 (Ile105→Val) in 100 COPD patients and 100 age- and sex-matched healthy controls.
Results The proportion of mEH exon 3 heterozygotes was significantly higher in patients with COPD than that in the control subjects (42% vs 32%). The odds ratio (OR) adjusted by age, sex, body mass index (BMI) and cigarette years was 2.96 (95%CI 1.24-7.09). There was no marked difference in very slow activity genotype versus other genotypes between COPD patients and the controls. When COPD patients were non-smokers, the OR of very slow activity genotype versus other genotypes was more than 1.00; and when COPD patients were smokers (current smokers and ex-smokers), the OR was less than 1.00. There was no significant difference in GSTP1 polymorphism adjusted by age, sex, BMI and smoking between COPD patients and the controls.
Conclusions mEH exon 3 heterozygotes might be associated with susceptibility to COPD in China. The interaction might exist between mEH genotype and smoke. The gene polymorphism for GSTP1 might not be associated with susceptibility to COPD in the Chinese population.

Chinese Medical Journal 2004;117(5):661-667
This study was supported by : National Science and Technology Project(No.2001BA703B03 (A)) Beijing Natural Science Fund Imbursement Project(No.7022014)
Free Full Text [ Fulltext HTMLHTML | Full PDFPDF(-) ] Abstract download [TXT | XML]
XIAO Dan 肖 丹 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; WANG Chen 王 辰 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; DU Min-jie 杜敏捷 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; PANG Bao-sen 庞宝森 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; ZHANG Hong-yu 张洪玉 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; XIAO Bai 肖 白 Research Center of Preclinical Medicine, Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; LIU Jing-zhong 刘敬忠 Research Center of Preclinical Medicine, Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; WENG Xin-zhi 翁心植 Beijing Institute of Respiratory Medicine,Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing 100020, China; SU Li 苏 丽 Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA; David C.Christiani Occupational Health Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA

Correspondence to: Xiao Dan,  Department of Respiratory Disease, Beijing Tiantan Hospital, Beijing 100050, China  (Tel:86-10-65060167 Fax:86-10-65060167 Email:luaixiao@sina.com )
 
  Rapid Response | more responses(0)
Name Emailanonymous | Login
  Related Articles
No related article.
 

©2005-2008 Chinese Medical Journal, All Rights Reserved. ICP:05052599

Chinese Medical Assoication  Open Access  Creative Commons   Free Charge  第二届国家期刊奖百种重点期刊  中国期刊方阵双高期刊  国家自然科学基金重点学术期刊专项基金